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ABSTRACT
BACKGROUND AND PURPOSE: Transverse sinus stenosis can lead to pseudotumor cerebri syndrome by elevating the cerebral venous
pressure. The occipital emissary vein is an inconstant emissary vein that connects the torcular herophili with the suboccipital veins of the
external vertebral plexus. This retrospective study compares the prevalence and size of the occipital emissary vein in patients with
pseudotumor cerebri syndrome with those in healthy control subjects to determine whether the occipital emissary vein could represent
a marker of pseudotumor cerebri syndrome.
MATERIALS AND METHODS: The cranial venous system of 46 adult patients with pseudotumor cerebri syndrome (group 1) was studied
on CT venography images and compared with a group of 92 consecutive adult patients without pseudotumor cerebri syndrome who
underwent venous assessment with gadolinium-enhanced 3D-T1 MPRAGE sequences (group 2). The presence of an occipital emissary vein
was assessed, and its proximal (intraosseous) and distal (extracranial) maximum diameters were measured and compared between the 2
groups. Seventeen patients who underwent transverse sinus stent placement had their occipital emissary vein diameters measured before
and after stent placement.
RESULTS: Thirty of 46 (65%) patients in group 1 versus 29/92 (31.5%) patients in group 2 had an occipital emissary vein (P  .001). The average
proximal and distal occipital emissary vein maximum diameters were significantly larger in group 1 (2.3 versus 1.6 mm, P .005 and 3.3 versus
2.3 mm, P  .001). The average maximum diameters of the occipital emissary vein for patients who underwent transverse sinus stent placement
were larger before stent placement than after stent placement: 2.6 versus 1.8 mm proximally (P  .06) and 3.7 versus 2.6 mm distally (P  .005).
CONCLUSIONS: Occipital emissary veins are more frequent and larger in patients with pseudotumor cerebri syndrome than in healthy
subjects, a finding consistent with their role as collateral venous pathway in transverse sinus stenosis. A prominent occipital emissary vein
is an imaging sign that should raise the suspicion of pseudotumor cerebri syndrome.
ABBREVIATIONS: OEV  occipital emissary vein; MDCT  multidetector row CT; PTCS  pseudotumor cerebri syndrome; SCTV  subtracted CT venography
Emissary veins of the skull base and posterior fossa play animportant role in directing cerebral venous blood toward cer-
vical outflow pathways.1,2 Emissary veins include the anterior,
posterior, and lateral condylar emissary veins, the mastoid emis-
sary vein, and the occipital emissary vein (OEV).1 The OEV is
located at or close to the midline of the occipital squama and
connects the torcular herophili or distal superior sagittal sinus to
the suboccipital veins that drain into the vertebral artery venous
plexus, the deep cervical vein, or both (Fig 1).3 The OEV, when
present, may connect with the diploic veins of the occipital and
parietal bones. Due to its proximal location, the OEV is the
only emissary vein of the skull base/posterior fossa that can
provide a derivation pathway for the transverse sinus (Fig 2).
The reported prevalence of the OEV is highly variable, ranging
from 0.46% to 58.33%.3-12 The OEV, however, has received
little attention in the anatomic, surgical, and radiologic litera-
ture. Enlarged OEVs have been described in craniosynostosis,
increased intracranial pressure, and transverse sinus or sig-
moid sinus thrombosis.13-15
Pseudotumor cerebri syndrome (PTCS), also known as idio-
pathic or benign intracranial hypertension, is characterized by
increased intracranial pressure, which may lead to complete loss
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of vision and disabilities due to intractable headaches or pulsatile
tinnitus.16-20
Dural sinus venous outflow obstruction may be observed in
up to 93% of patients with PTCS and plays an important role in
the syndrome pathophysiology.21,22 Transverse sinus stenosis is
the most sensitive sign of PTCS on MR imaging.23 Stenosis may be
primary (intrinsic), principally due to thrombosis or arachnoid
granulation with or without brain herniation,24 or secondary (ex-
trinsic), mainly in relation to increased CSF pressure.25 PTCS may
also be observed in dural arteriovenous fistulas due to arterio-
venous shunting and venous restrictive disease.26 The cranial ve-
nous system should therefore be studied in detail in all patients
with PTCS to rule out an intrinsic/extrinsic stenosis or an arterio-
venous shunt and as a preplanning technique when considering
dural venous sinus stent placement. Du-
ral sinus stent placement is being used
increasingly to treat PTCS that is refrac-
tory to medical management as an alter-
native to ventricular shunting, and has
also been used in patients with PTCS
with severe pulsatile tinnitus or malig-
nant PTCS with rapidly evolving vision
loss.27,28
PTCS imaging findings include an
enlarged “empty sella,”29 optic nerve ab-
normalities (papilledema and tortuous
optic nerves), dilated subarachnoid
spaces around cranial nerves (optic
nerve sheaths, the Meckel cave, an ocu-
lomotor nerve within the lateral wall of
the longitudinal sternal stabilization sys-
tem, Dorello canal, and so forth),29-31
and venous outflow restriction. Promi-
nent OEVs may be commonly observed
during clinical routine in patients with
PTCS with transverse sinus stenosis and
not in healthy individuals. The OEVs in
patients with PTCS and transverse sinus
stenosis may be increased in size because
they serve as a venous collateral. The pur-
pose of our study was to evaluate the prev-
alence and size of the OEV in patients with
PTCS and in healthy controls and to deter-
mine whether the OEV could represent a
marker of venous PTCS.
MATERIALS AND METHODS
This was a retrospective case-control
study. Informed consent for imaging
and dural venous sinus stent placement
was obtained from all patients with
PTCS. In addition, all patients had given
consent to being included in an institu-
tional review board–approved data base
at Johns Hopkins Hospital, authorizing
analysis of data obtained during routine
diagnostic and interventional clinical
activity.
The cranial venous system of 46 adult patients with PTCS
(group 1) was studied on subtracted CT venography (SCTV) im-
ages obtained on a 320 – detector row multidetector row CT
(MDCT) scanner (Aquilion ONE CT scanner; Toshiba Medical
Systems, Tokyo, Japan). All patients satisfied the modified Dandy
criteria for PTCS, were not pregnant, and were not on medica-
tions or had medical conditions associated with intracranial hy-
pertension. None of these patients had undergone shunt or bari-
atric surgery. Technical parameters were as follow: 0.5-mm
detector width, 0.25-mm reconstruction interval, 512  512 ma-
trix, 160-mm FOV, 0.75-second scan rotation time, 80-kV tube
voltage, and 150- to 280-mA tube current. A native head CT vol-
ume scan was obtained and used as a mask for subtraction. There-
FIG 1. MR imaging of the craniocervical region in healthy subjects: gadolinium-enhanced 3D-T1
MPRAGE sagittal acquisitions, thick MIP reconstructions (FOV  232  256 mm2, matrix  232 
256, slice thickness  1 mm, slices per slab  160 –208, TR/TE  2200/2.09 – 4.68 ms, bandwidth 
140 –240 Hz/pixel.) Parallel acquisition was performed in the generalized autocalibrating partially
parallel acquisition mode, with reference line phase encoding. A, Classic OEV origin from the
torcular herophili (asterisk). The OEV courses intraosseously within the occipital squama (arrows)
and exists the skull proximal to the foramen magnum to join the suboccipital veins. B, An OEV
originating from the distal superior sagittal sinus. The black arrow indicates the superior sagittal
sinus; the black arrowhead, the straight sinus.
FIG 2. Venous phase of an SCTV obtained with a 320 – detector row MDCT in a patient with
pseudotumor cerebri syndrome. Posterior (A) and right lateral (B) projections. A dilated OEV
(double arrows) originates from the torcular herophili (asterisk), consisting of several intraosse-
ous and extracranial veins with various exit zones from the occipital squama. A hypoplastic
transverse sinus is documented on the right side (thick arrow), and a severe transverse sinus
intrinsic stenosis from an arachnoid granulation is seen on the left side (thin arrow). The double
arrowheads indicate the superior sagittal sinus.
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after, 50 mL of nonionic contrast material (iopamidol, Isovue
370; Bracco, Princeton, New Jersey) was injected intravenously at
a flow rate of 6 mL/s followed by a saline flush. The dynamic
volume CT angiography followed with 5 volume scans in the ar-
terial phase at 15–25 seconds and 7 volume scans in the venous
phase at 30 – 45 seconds postinjection. Poststenting follow-up im-
aging was acquired 6 months after the procedure.
A group of 92 adult patients who underwent MR imaging for
routine medical studies (1.5T, Aera; Siemens Erlangen, Germany)
with gadolinium-enhanced 3D-T1 MPRAGE sequences was used
as controls (group 2). Inclusion criteria were adults between 18
and 60 years of age and the availability of gadolinium-enhanced
3D-T1 MPRAGE images. Excluded were patients with clinical
and/or radiologic evidence of PTCS, intracranial venous throm-
bosis, dural sinus stenosis, intracranial arteriovenous shunts, pos-
terior fossa surgery, posterior fossa tumor and evidence of in-
creased intracranial pressure. MR imaging parameters were as
follows: 232  256 mm FOV, 232  256 matrix, 1-mm slice thick-
ness, 160 –208 slices per slab, TR/TE  2200/2.09 – 4.68 ms, 140-
to 240-Hz/pixel bandwidth. A parallel acquisition was conducted
in the generalized autocalibrating partially parallel acquisition
mode with reference line phase encoding; 0.1 mmol/kg of gado-
linium (gadoterate meglumine, Dotarem; Guerbet, Aulnay-sous-
Bois, France; or gadobenate dimeglumine, MultiHance; Bracco
Diagnostics, Princeton, New Jersey) was injected in each patient.
When available, CT images (64 – detector row MDCT, Optima
MR450w with GEM Suite; GE Healthcare, Milwaukee, Wiscon-
sin) in patients from group 2 were studied (bone algorithm
reconstructions).
Image Analysis
Consensual analysis of the imaging data was performed by 2 se-
nior radiology residents (A.H., A.P.) and a senior, board-certified
neuroradiologist (D.S.M.). SCTV for group 1 and gadolinium
3D-T1 MPRAGE MR imaging of group 2 were evaluated for the
presence of an OEV. When an OEV was visible, maximum diam-
eters were measured at its proximal osseous segment in the occip-
ital squama and extracranially immediately in front of the OEV
foramen. For the control group, the presence of the osseous canal
corresponding to the OEV was also assessed on CT (64 – detector
row MDCT) when available.
For patients who underwent transverse sinus stent placement
and for whom a follow-up SCTV was available, the size of the OEV
was measured in the same location before and after the procedure.
Follow-up SCTV was performed within 2 days poststenting.
Statistical Analysis
The number of patients was restricted to
those available in our center (monocen-
tric study). To increase the statistical
power, we recruited 2 controls for each
patient. The 2:1 ratio would also com-
pensate for the smaller frequency of
visible veins in the control group to im-
prove the statistical power of the com-
parison of vein sizes between groups. No
pairing was performed because it would
have reduced the number of subjects and would prevent any com-
parison on pairing variables. With 46 patients and 92 controls, a
2-sided type I error rate set at 0.05, an expected proportion of
controls with a visible vein equal to 30%, and an expected pro-
portion of patients with a visible vein equal to 65%, the statistical
power would be to 45%.
Data are presented as median and range for continuous vari-
ables and as a percentage for frequency data. Statistical analysis of
frequency data was performed using a Fisher exact test. Continu-
ous variables were compared using a Student t test. A P value 
.05 was considered statistically significant. Statistical analysis was
performed using the Statistical Toolbox in Matlab (MathWorks,
Natick, Massachusetts).
RESULTS
Patient demographics are summarized in Table 1. Patients with
PTCS and control subjects were similar in overall profile. Patients
with PTCS had a slightly greater preponderance of women.
Forty-six patients were included in the PTCS group (87% were
women with an average age of 36 years), and MR imaging studies
from 92 consecutive patients meeting the selection criteria were
included in the control group (67% were women with an average
age of 41 years). No patient was further excluded from analysis
after inclusion.
An OEV was observed in 30 of the 46 patients in group 1
(65.2%) and 29 of the 92 patients in group 2 (31.5%) (P  .0003).
The prevalence of an OEV for men and women was similar in
groups 1 and 2.
The average diameter of the OEV in its osseous segment (prox-
imal) was 2.3 mm (range, 1–7 mm) in group 1 and 1.6 mm (range,
0.5–3 mm) in group 2 (P  .0049). Extracranially, at the exit of the
OEV foramen, the average OEV diameter was 3.3 mm in group 1
(range, 1.8 –10 mm) and 2.3 mm (range, 1–7 mm) in group 2 (P 
.0001). The average proximal and distal OEV maximum diame-
ters were therefore both significantly larger in group 1. OEV char-
acteristics are summarized in Table 2.
In group one, 29 of the 46 patients (63%) underwent trans-
verse sinus stent placement; 17 had a poststenting control CT
venography at the time of review (Fig 3). Poststent placement
reduction in the size of the OEV was observed in 9/17 cases (53%).
In 2 cases, the reduction was only visible in the extracranial por-
tion, and in 1 case, the OEV was no longer visible. The average
maximum diameters of the OEV before and after stent placement
were, respectively, 2.6 versus 1.8 mm proximally (intraosseous
segment, P  .06) and 3.7 versus 2.6 mm distally (extracranial
Table 1: Characteristics of patients with PTCS and the control group
PTCS (n = 46) Control (n = 92) P Value
Age (mean) (yr) 35.6  9.9 41.1  12.3 .01
Female/male 40:6 62:30 .01
CSF opening pressure (mean)
(range) (cm H2O)
34  9 (22–65)
(n  44/46)
Patients treated with stenting 29/46
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portion, P  .0045). OEV characteristics results before and after
stent placement are summarized in Table 3.
The exit point of the OEV was, in both groups, always located
between the external occipital protuberance and the foramen
magnum. Multiple OEVs were found in 3.2% of cases in group 2,
two OEVs on 2 occasions and a triple OEV once. On 1 occasion,
the OEV took its origin from the distal superior sagittal sinus and
not the torcular herophili (Fig 1B).
At the time of data collection for group 1, a sufficient number
of SCTVs of healthy patients that could be used as a healthy con-
trol population for group 2 were not
available. Thus, group 2 was based on
MR imaging data using gadolinium-en-
hanced 3D-T1 MPRAGE. Gadolinium-
enhanced 3D-T1 MPRAGE provides
very good depiction of diploic veins and
was thought to reliably demonstrate the
prevalence of an OEV.32 In group two,
75% of patients had CT data available.
One hundred percent of OEVs observed
on MR imaging were visible on CT. In 4
patients (4.3%), an OEV canal was visi-
ble on CT but no visible OEV was found
on MR imaging, which could be due to
the OEV having become atretic with
time. MR imaging could therefore be
less sensitive than CT for detecting
OEVs in a small percentage of patients,
though in these cases, the OEV may not
be functional (atretic).
DISCUSSION
Venous outflow obstruction is increas-
ingly recognized as an etiology of PTCS,
and transverse sinus stenosis is consid-
ered a sensitive sign of the condition.23
The observation of very prominent
OEVs in patients with PTCS led us to
investigate the size and prevalence of
OEVs in these patients and in healthy
controls.
The OEV has received little attention
in the literature. The few anatomic stud-
ies available were conducted on dry
skulls. OEV foramina prevalence varied
significantly among studies, ranging
from as low as 0.46% up to 58% (On-
line Table). In our study, an OEV was
present in 65% of patients with PTCS
and 30% of control subjects. In terms of
OEV prevalence, 1 study presented re-
sults similar to those in our PTCS group
(group 1),11 and another showed results
similar to those in our control group
(group 2).12 Overall, a higher OEV prev-
alence was found in both groups com-
pared with the prevalence previously re-
ported in the anatomic literature. This
prevalence is surprising considering that even the smallest bone
foramina should be detectable on dry skulls. On the other hand,
occipital squama foramina may account not only for OEVs but
also exit zones of regional diploic veins, potentially leading to
OEV prevalence overestimation on dry skull specimens.
When we considered discrepancies in size measurements ob-
tained on CT and MR imaging,33 OEVs were significantly larger in
patients with PTCS (group 1), all of whom had transverse sinus
stenosis, than in control subjects without venous outflow obstruc-
tion (group 2). Surprisingly, however, the prevalence of OEV in
FIG 3. Venous phase of an SCTV with a 320 – detector row MDCT in a patient with pseudotumor
cerebri syndrome before (A and B) and after (C and D) left transverse sinus stent placement,
anterior Towne projections (A and C), and left posterior oblique projections (B and D). There is a
marked reduction of the OEV (small arrow) after stent placement in the left transverse sinus
(double arrows), which has recovered its normal caliber. Note the size reduction of the right
transverse sinus (arrowhead) proximal to an intrinsic stenosis after stent placement due to
preferential drainage of the superior sagittal sinus into the stented transverse sinus.




(Control) (n = 92) P Value
Prevalence of OEV (No.) 65.2% (30) 31.5% (29) .0003
Male 4/6 (66.6%) 9/30 (30.0%)
Female 24/40 (60.0%) 20/62 (32.2%)
Osseous segment diameter (mean)
(range) (mm)
2.3 (1–7) 1.6 (0.5–3) .0049
Extracranial segment diameter (mean)
(range) (mm)
3.3 (1.8–10) 2.3 (1–7) .0001





(n = 17) P Value
Osseous segment diameter (mean) (range) (mm) 2.6 (1.5–4) 1.8 (1–2.1) .06
Extracranial segment diameter (mean) (range) (mm) 3.7 (2–7) 2.6 (1–3.25) .0045
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patients with PTCS was significantly higher than in control sub-
jects (65.2% versus 31.5%). OEVs missed by the imaging protocol
in group 2 consisting of gadolinium 3D-T1 MPRAGE and dry CT
(in most cases) could explain this discrepancy, though both tech-
niques successfully detected OEVs as small as 0.5 mm. Alterna-
tively, venous hypertension (demonstrated by intravenous pres-
sure measurements in all patients with PTCS) may recanalize
atretic OEVs or render more conspicuous very small OEVs that
would otherwise be undetectable in normal conditions.
The OEV is the only potential venous collateral pathway of the
posterior fossa in cases of transverse sinus or proximal sigmoid
sinus stenosis aside from the parietal emissary veins of Santorini,
which were not studied here. Other posterior fossa emissary veins
such as the mastoid or posterior condylar emissary veins1 are
located downstream from the transverse sinus stenosis generally
encountered in PTCS. Although the size of OEVs significantly
increases in PTCS, it did not represent a functionally efficient
derivation pathway because all our patients were clinically symp-
tomatic. The ability of the OEV to represent a successful collateral
pathway is likely limited by its intraosseous portion, which prob-
ably restricts the degree of OEV dilation. Indeed, OEV diameters
were, in all cases, larger extracranially than in the osseous portion.
The role of the OEV as a collateral venous pathway is, however,
supported by its regression in 53% of the stented patients with
PTCS.
The OEV anatomy in group 2 was otherwise consistent with
classic descriptions. Its origin was from the distal superior sagittal
sinus on 1 occasion (1%), and multiple OEVs were observed in 3
healthy subjects (2 double OEVs, 1 triple OEV).
There are limitations to this study. First, the retrospective na-
ture of the analysis and lack of blinding could limit the general-
ization of our findings. Different imaging modalities were used to
compare a group of patients with PTCS (SCTV) with a control
group of healthy individuals (MR imaging). The study design
sizes of OEVs obtained through CT and MR imaging measure-
ments could, therefore, be partly explained by differences in size
rendering between the 2 techniques, especially given the small size
of the evaluated anatomic structures (several millimeters). The
sensitivity of MR imaging in detecting the OEV was also likely
lower than in CT (4.3% of OEV canals on CT did not contain an
OEV on MR imaging), possibly due to atretic OEVs. This likeli-
hood could explain the higher prevalence of OEVs in the PTCS
group than in the control group. Indeed, elevated venous pressure
in dural sinuses proximal to the transverse sinus stenosis could
lead to recanalization of an atretic OEV.
CONCLUSIONS
The OEV diameter in patients with PTCS is larger than in healthy
subjects, a finding consistent with its role as a collateral venous
pathway in transverse sinus stenosis. An OEV is more frequent in
patients with PTCS than in healthy subjects, even though the
prevalence of OEVs in the latter group was found to be higher
than previously reported in the literature. A prominent OEV on
CT should prompt the radiologist to look for other signs of PTCS
and suggest a CT- or MR imaging– based venous study. Promi-
nent occipital emissary veins may be a valuable secondary sign
prompting further investigation.
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